Status:
COMPLETED
Effects of Incretins on Human Platelet Function
Lead Sponsor:
National Council of Scientific and Technical Research, Argentina
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Inhibition of Platelet Aggregation by Incretins
Eligibility:
All Genders
21-65 years
Brief Summary
Novel drugs for the treatment of patients with diabetes are of interest for cardiologists if they reduce the risk of cardiovascular events. However, as documented by the current discussion about the p...
Detailed Description
Aims and Methods: The prevalence of Type 2 diabetes (T2D) continues to increase globally and brings with it a parallel increase in the associated cardiovascular disease complications. Correction of pl...
Eligibility Criteria
Inclusion
- Healthy blood donors
Exclusion
- Diabetes
- Hypertension
- Morbid obesity
- Cardiovascular disease
- Hematological diseases and hyperlipidemia
Key Trial Info
Start Date :
December 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01408862
Start Date
December 1 2012
End Date
August 1 2014
Last Update
September 23 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.